Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2020 · 10-Q
Revenue$374.70M$374.70M−15.9% vs Q2 2019 Net Income-$32.50M-$32.50MN/M vs Q2 2019 EPS Diluted-$0.86-$0.86N/M vs Q2 2019 Operating Income$44,700,000−19.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$173,800,000+2,494.0% Margins · derivedOperating margin11.9%−0.5 pt vs Q2 2019
Net margin-8.7%−4.2 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 5, 2020 · 36 d after period end